| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/13/1993 | EP0522070A1 MOLECULAR CLONING OF THE GENES RESPONSIBLE FOR COLLAGENASE PRODUCTION FROM $i(CLOSTRIDIUM HISTOLYTICUM) |
| 01/13/1993 | EP0521986A1 Topically active ocular gem-diacylthiadiazole sulfonamide carbonic anhydrase inhibitors |
| 01/13/1993 | EP0329708B1 Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid |
| 01/12/1993 | US5179216 Anticholesterol agents and atherosclerosis |
| 01/12/1993 | US5179110 Adrenergic stimulants; antiulcer agents, bronchodilators, treatment of diarrhea, glaucoma, osteoporisis, prostate, diabetes, migraine |
| 01/12/1993 | US5179108 Derivatives of 4-(aminomethyl) piperidine, their preparation and their therapeutic application |
| 01/12/1993 | US5179106 Enzyme inhibitors; respiratory system disorders |
| 01/12/1993 | US5179091 Chalcones |
| 01/12/1993 | US5178864 Anticholesterol phospholipase |
| 01/11/1993 | CA2071137A1 Composition and method for revitalizing scar tissue |
| 01/09/1993 | WO1993000921A1 Remedy for osteoporosis |
| 01/09/1993 | CA2090453A1 Remedy for osteoporosis |
| 01/09/1993 | CA2073326A1 Method of inhibiting sucrase activity |
| 01/09/1993 | CA2046484A1 Peptides |
| 01/07/1993 | WO1993000343A1 Thiazolidinedione hypoglycemic agents |
| 01/07/1993 | WO1993000337A1 (s)(+)-2-ethoxy-4-[n-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid |
| 01/07/1993 | WO1993000092A1 Improved process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates |
| 01/07/1993 | WO1993000052A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | WO1993000051A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | EP0521787A1 Vanadium complexes, their preparation and pharmaceutical compositions containing them |
| 01/07/1993 | EP0521550A2 Vitamin D compound, method of preparing this compound and intermediate therefor |
| 01/07/1993 | EP0521471A1 Pyrimidine derivatives as HMG-CoA reductase inhibitors |
| 01/07/1993 | EP0520987A1 METHOD OF SUPPRESSING APPETITE BY ADMINISTRATION OF TETRAHYDRO-$g(b)-CARBOLINE DERIVATIVES |
| 01/07/1993 | CA2112376A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | CA2112375A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/05/1993 | US5177198 Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates |
| 01/05/1993 | US5177104 6-α-hydroxy derivatives of mevinic acids |
| 01/05/1993 | US5177080 Substituted pyridyl-dihydroxy-heptenoic acid and its salts |
| 01/05/1993 | US5177058 Insulin derivatives |
| 01/05/1993 | US5177017 Molecular cloning of the genes responsible for collagenase production from Clostridium histolyticum |
| 01/05/1993 | CA1312333C Strontium salt, its preparation process and the pharmaceutical compositions containing it |
| 01/05/1993 | CA1312330C Heterocyclic compounds, a process for their preparation and their use in medicine |
| 01/05/1993 | CA1312286C Pharmaceutical preparation containing metoprolol |
| 01/04/1993 | CA2072938A1 Vanadium complexes, process for their preparation and pharmaceutical compositions holding same |
| 01/02/1993 | CA2072834A1 Ketone derivatives |
| 12/30/1992 | EP0520552A1 Derivatives of (hetero) aromatic ethers and thioethers having antihyperlipidemic activity, process for their preparation and pharmaceutical compositions containing them |
| 12/30/1992 | EP0520427A1 Cyclopropenone derivatives |
| 12/30/1992 | EP0520320A2 Tetrahydropyrrolo 1,2-a pyrazine-4-spiro-3'-pyrrolidine derivatives, processes for the preparation thereof and pharaceutical compositions containing the same |
| 12/30/1992 | EP0520112A1 Dermatological composition based on an aqueous phase |
| 12/30/1992 | EP0519996A1 Imidazoles |
| 12/30/1992 | EP0211863B1 Vitamin d derivatives and methods for preparing same |
| 12/30/1992 | CN1067427A Pyrazolopyridine compound and processes for preparation thereof |
| 12/29/1992 | US5175188 Ascorbic acid derivatives |
| 12/29/1992 | US5175146 Synthetic calcitonin peptides |
| 12/29/1992 | CA2071655A1 Sporormiella intermedia and processes therefrom |
| 12/29/1992 | CA1312083C Hydantoin derivatives |
| 12/23/1992 | WO1992022638A1 Perilipin |
| 12/23/1992 | WO1992022329A1 USE OF β-CELL TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF HYPERINSULINAEMIA AND ASSOCIATED DISEASES |
| 12/23/1992 | WO1992022328A1 USE OF β-CELL-TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF TYPE II DIABETES AND ASSOCIATED DISEASES |
| 12/23/1992 | WO1992022307A1 Remedy for chronic fatigue syndrome |
| 12/23/1992 | WO1992022305A1 Therapeutic composition for sustained release of magnesium |
| 12/23/1992 | EP0519750A2 Insulin analogs |
| 12/23/1992 | EP0519673A1 Composition containing dioxabicyclo[3.3.0]octane derivative |
| 12/23/1992 | EP0519119A1 Polyamides bearing functionalized side chains useful as water soluble hypolipidemic agents |
| 12/23/1992 | EP0518960A1 Derivatives of n-phenyl glycinamide, their preparation and medicaments containing them. |
| 12/23/1992 | EP0518943A1 Mercaptoacyl aminolactam endopeptidase inhibitors |
| 12/23/1992 | EP0460080B1 Orally administerable calcium supplement for cattle |
| 12/23/1992 | CN1019571B Process for preparation of diphenylpropylamine derivatives and their salts |
| 12/23/1992 | CA2111584A1 Use of b-cell tropin (acth 22-39) antagonists in the treatment of hyperinsulinaemia and associated diseases |
| 12/23/1992 | CA2111583A1 Use of b-cell-tropin (acth 22-39) antagonists in the treatment of type ii diabetes and associated diseases |
| 12/22/1992 | US5173502 For treating depression, hypertension, parkinson*s disease, asthma, convulasions, platelet aggregation of metabolic disorders |
| 12/22/1992 | US5173498 Substituted 3-thia- and 3-oxa-alkylflavones, a process for their preparation, the use thereof, medicaments based on these compounds and intermediates |
| 12/22/1992 | US5173493 For treatment or prevention of nausea or vomiting |
| 12/22/1992 | US5173487 Mevinic acid derivatives |
| 12/22/1992 | CA2071382A1 Insulin analogs |
| 12/22/1992 | CA1311767C 5-substituted ornithine derivatives |
| 12/19/1992 | CA2056035A1 Polyamides bearing functionalized side chains useful as water soluble hopolipidemic agents |
| 12/16/1992 | EP0518769A1 Ethanolaminebenzoate derivative, process for their preparation and pharmaceutical compositions containing them |
| 12/16/1992 | EP0518722A1 Dithiane substituted retinoides, their use, process of their preparation, cosmetic and pharmaceutical compositions containing them and their use in therapeutics |
| 12/16/1992 | EP0518587A2 A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production |
| 12/16/1992 | EP0517817A1 Inhibitors of catalytic antibodies |
| 12/16/1992 | EP0517789A1 Inhibitor of proliferation of endothelial cells. |
| 12/16/1992 | CN1019488B Dihydropyridinelactois process for their preparation and their use as medicaments |
| 12/16/1992 | CN1019451B Cycioalkyliamides of (8beta)-1-alkyl-6-(substituted) ergolines |
| 12/15/1992 | US5171752 Treating ischemia and angina |
| 12/15/1992 | US5171670 Recombinant dna method for production of parathyroid hormone |
| 12/15/1992 | CA2071143A1 Squalene synthetase inhibitors and processes therefrom |
| 12/15/1992 | CA1311483C 5-pyrazolylcarbonyl- and 5-pyrazolyvinyl-phenoxy acetic acid derivatives and processes for preparing the same |
| 12/15/1992 | CA1311475C Process for preparing partial polyol fatty acid esters |
| 12/15/1992 | CA1311474C Process for preparing polyol fatty acid polyesters |
| 12/15/1992 | CA1311417C Antidiabetic composition comprising 7-thiaprostaglandin e _or its derivative |
| 12/11/1992 | WO1992022299A2 Use of antiarrhythmic agents to lower cholesterol |
| 12/11/1992 | CA2089164A1 Use of antiarrhythmic agents to lower cholesterol |
| 12/10/1992 | WO1992021756A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose |
| 12/10/1992 | WO1992021749A1 Trace element-rich additive, method for preparing same, preparation in which the additive is included and use thereof |
| 12/10/1992 | WO1992021360A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents |
| 12/10/1992 | WO1992021354A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 12/10/1992 | WO1992021342A1 Antidiabetic |
| 12/10/1992 | WO1992021336A1 Cholesterol-lowering tocopherol analogs |
| 12/10/1992 | WO1992019617A3 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 12/10/1992 | CA2110256A1 Trace element-rich additive, method for preparing same, preparation in which the additive is included and use thereof |
| 12/10/1992 | CA2103365A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose |
| 12/10/1992 | CA2102890A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents |
| 12/10/1992 | CA2088582A1 Anti-diabetes mellitus |
| 12/09/1992 | EP0517425A1 Fatty acids for the reduction of urinary calcium excretion and the treatment of osteoporosis |
| 12/09/1992 | EP0516941A1 Pyrazolopyridine compounds and processes for preparation thereof |
| 12/09/1992 | EP0516704A1 Novel insulin compositions. |
| 12/08/1992 | US5169976 N-(biphenylmethyl)-3-hydroxyglutaramic acid and derivatives as hypocholesterolemic agents |
| 12/08/1992 | US5169947 Therapy for obesity, depression |
| 12/08/1992 | CA1311243C PHARMACEUTICAL COMPOSITIONS CONTAINING .alpha.-HALOGENATED DICARBOXYLIC ACIDS |